AQP4 and myeloid sarcoma: Autoantibodies against AQP1 (AQP1-Abs) were found among patients in the high risk group (characterized by presence of AQP4 autoantibodies with early forms of LETM or optic neuritis [70]) and diagnosed with NMO and/or MS [71,72,73].